+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hovid Berhad - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 28 Pages
  • October 2023
  • GlobalData
  • ID: 5228452
Hovid Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - A summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Hovid Berhad (Hovid), formerly known as Ho Yan Hor, manufactures and commercializes pharmaceutical, herbal products, and health supplements. The company’s product portfolio consists of ethical drugs, pharmaceutical products, dietary supplements, tocotrienols, herbal tea, medical devices and consumer products. Hovid also specializes in special drug delivery systems including modified release formulations and bio-availability enhanced formulations. It offers consumer products including nasal solution, creams, hygiene, and body wash products. Hovid manufactures products by outsourcing through contracts with third parties. The company has operations in Africa, Asia, the Americas, Europe, and the Pacific Islands. Hovid is headquartered in Ipoh, Perak, Malaysia.

Hovid Berhad Key Recent Developments

  • Sep 21,2022: Hovid Awarded TGA-GMP Certification, Enable Expansion into Global Markets

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Hovid Berhad - Key Facts
  • Hovid Berhad - Key Employees
  • Hovid Berhad - Key Employee Biographies
  • Hovid Berhad - Key Operational Employees
  • Hovid Berhad - Major Products and Services
  • Hovid Berhad - History
  • Hovid Berhad - Company Statement
  • Hovid Berhad - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Hovid Berhad - Business Description
  • R&D Overview
  • Hovid Berhad - SWOT Analysis
  • SWOT Analysis - Overview
  • Hovid Berhad - Strengths
  • Hovid Berhad - Weaknesses
  • Hovid Berhad - Opportunities
  • Hovid Berhad - Threats
  • Hovid Berhad - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Hovid Berhad, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Sep 21, 2022: Hovid Awarded TGA-GMP Certification, Enable Expansion into Global Markets
Section 5 - Appendix
  • Methodology
  • Contact Us
  • Disclaimer
List of Tables
  • Hovid Berhad, Key Facts
  • Hovid Berhad, Key Employees
  • Hovid Berhad, Key Employee Biographies
  • Hovid Berhad, Key Operational Employees
  • Hovid Berhad, Major Products and Services
  • Hovid Berhad, History
  • Hovid Berhad, Subsidiaries
  • Hovid Berhad, Joint Venture
  • Hovid Berhad, Key Competitors
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Hovid Berhad, Recent Deals Summary
List of Figures
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Hovid Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Kotra Industries Berhad
  • Pharmaniaga Berhad
  • Chemical Company of Malaysia Bhd
  • Apex Healthcare Berhad
  • Y.S.P. Southeast Asia Holding Berhad